Baseline characteristics | n = 27 |
Age (years), mean ± SD | 57.7 ± 6.89 |
Gender, male n (%) | 21 (77.8%) |
Body mass index, mean ± SD | 23.6 ± 3.4 |
Systolic blood pressure, mmHg, mean ± SD | 119.37 ± 9.39 |
Heart rate, bpm, mean ± SD | 71.81 ± 5.04 |
NYHA classification | |
NYHA III, n (%) | 15 (55.6%) |
NYHA IV, n (%) | 12 (44.4%) |
6 MWT (m), mean ± SD | 148.56 ± 38.54 |
Medical history | |
Hypertension, n (%) | 6 (22.2%) |
Diabetes mellitus, n (%) | 15 (55.5%) |
Atrial fibrillation, n (%) | 4 (14.8%) |
Family history with HF, n (%) | 2 (7.4%) |
Smoker, n (%) | 19 (70.3%) |
Baseline medication | |
ACE inhibitor, n (%) | 17 (62.9%) |
ARB, n (%) | 9 (33.3%) |
β-Blocker, n (%) | 22 (81.4%) |
Sacubitril/valsartan, n (%) | 1 (3.7%) |
Aldosterone antagonist, n (%) | 11 (40.7%) |
Diuretic, n (%) | 6 (22.2%) |
Statin, n (%) | 22 (81.4%) |
Echocardiographic parameters | |
Diastolic dysfunction grade I, n (%) | 2 (7.4%) |
Diastolic dysfunction grade II, n (%) | 3 (11.1%) |
Diastolic dysfunction grade III, n (%) | 22 (81.5%) |
LVEF%, mean ± SD | 25.89 ± 7.4 |
End-systolic volume mL, mean ± SD | 126.8 ± 51.3 |
End-diastolic volume mL, mean ± SD | 190.7 ± 64.5 |
E, cm/s, median (IQR) | 100 (80–120) |
A, cm/s, median (IQR) | 25 (30–50) |
E/A, median (IQR) | 3.0 (2.3–3.66) |
E/E′ (cm/s), mean ± SD | 17.48 ± 5.21 |
Regurge volume/LA volume, mean ± SD | 27.05 ± 9.31 |
Vena contracta (mm), mean ± SD | 4.72 ± 1.27 |
PASP mmHg, mean ± SD | 39.56 ± 8.62 |
NO level IU/ml, mean ± SD | 4.05 ± 1.41 |